Exosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy.
Exosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy.
复制标题
DOI:
10.1038/srep23120
复制
发表时间:
2016-03-16
影响因子:
4.6
通讯作者:
Wu SC
中科院分区:
文献类型:
--
作者:
Xiao GY;Cheng CC;Chiang YS;Cheng WT;Liu IH;Wu SC
Chemotherapy (CTx)-induced premature ovarian failure (POF) in woman remains clinically irreversible. Amniotic fluid stem cells (AFSCs) have shown the potential to treat CTx-induced POF; however, the underlying mechanism is unclear. Here we demonstrate that AFSC-derived exosomes recapitulate the anti-apoptotic effect of AFSCs on CTx-damaged granulosa cells (GCs), which are vital for the growth of ovarian follicles. AFSC-derived exosomes prevent ovarian follicular atresia in CTx-treated mice via the delivery of microRNAs in which both miR-146a and miR-10a are highly enriched and their potential target genes are critical to apoptosis. The down-regulation of these two miRNAs in AFSC-derived exosomes attenuates the anti-apoptotic effect on CTx-damaged GCs in vitro. Further, the administration of these miRNAs recapitulates the effects both in vitro and in vivo, in which miR-10a contributes a dominant influence. Our findings illustrate that miR-10a has potential as a novel therapeutic agent for the treatment of POF.